176 related articles for article (PubMed ID: 19046477)
1. Cancer and immune-mediated disease in people who have had meningococcal disease: record-linkage studies.
Goldacre MJ; Wotton CJ; Yeates DG
Epidemiol Infect; 2009 May; 137(5):681-7. PubMed ID: 19046477
[TBL] [Abstract][Full Text] [Related]
2. Associations between infectious mononucleosis and cancer: record-linkage studies.
Goldacre MJ; Wotton CJ; Yeates DG
Epidemiol Infect; 2009 May; 137(5):672-80. PubMed ID: 18840316
[TBL] [Abstract][Full Text] [Related]
3. Risk of invasive pneumococcal disease in people admitted to hospital with selected immune-mediated diseases: record linkage cohort analyses.
Wotton CJ; Goldacre MJ
J Epidemiol Community Health; 2012 Dec; 66(12):1177-81. PubMed ID: 22493476
[TBL] [Abstract][Full Text] [Related]
4. Cancers and immune related diseases associated with Down's syndrome: a record linkage study.
Goldacre MJ; Wotton CJ; Seagroatt V; Yeates D
Arch Dis Child; 2004 Nov; 89(11):1014-7. PubMed ID: 15499053
[TBL] [Abstract][Full Text] [Related]
5. The tumor necrosis factor polymorphism TNF (-308) is associated with susceptibility to meningococcal sepsis, but not with lethality.
Read RC; Teare DM; Pridmore AC; Naylor SC; Timms JM; Kaczmarski EB; Borrow R; Wilson AG
Crit Care Med; 2009 Apr; 37(4):1237-43. PubMed ID: 19242354
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for invasive meningococcal disease in southern Queensland, 2000-2001.
McCall BJ; Neill AS; Young MM
Intern Med J; 2004 Aug; 34(8):464-8. PubMed ID: 15317544
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphism of the binding domain of surfactant protein-A2 increases susceptibility to meningococcal disease.
Jack DL; Cole J; Naylor SC; Borrow R; Kaczmarski EB; Klein NJ; Read RC
Clin Infect Dis; 2006 Dec; 43(11):1426-33. PubMed ID: 17083016
[TBL] [Abstract][Full Text] [Related]
8. Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern california-managed care organization.
Weng X; Liu L; Barcellos LF; Allison JE; Herrinton LJ
Am J Gastroenterol; 2007 Jul; 102(7):1429-35. PubMed ID: 17437504
[TBL] [Abstract][Full Text] [Related]
9. Underestimation of invasive meningococcal disease case fatality rates.
Crépey P; Getsios D
Clin Infect Dis; 2009 Oct; 49(7):1136-7; author reply 1137. PubMed ID: 19739964
[No Abstract] [Full Text] [Related]
10. Lack of association between group B meningococcal disease and autoimmune disease.
Howitz M; Krause TG; Simonsen JB; Hoffmann S; Frisch M; Nielsen NM; Robbins J; Schneerson R; Mølbak K; Miller MA
Clin Infect Dis; 2007 Nov; 45(10):1327-34. PubMed ID: 17968829
[TBL] [Abstract][Full Text] [Related]
11. Severity of meningococcal disease associated with genomic bacterial load.
Darton T; Guiver M; Naylor S; Jack DL; Kaczmarski EB; Borrow R; Read RC
Clin Infect Dis; 2009 Mar; 48(5):587-94. PubMed ID: 19191644
[TBL] [Abstract][Full Text] [Related]
12. Differential risks of cancer types in people with Parkinson's disease: a national record-linkage study.
Ong EL; Goldacre R; Goldacre M
Eur J Cancer; 2014 Sep; 50(14):2456-62. PubMed ID: 25065294
[TBL] [Abstract][Full Text] [Related]
13. Geographic and socioeconomic variation in meningococcal disease: a rural/urban comparison.
Olowokure B; Onions H; Patel D; Hooson J; O'Neill P
J Infect; 2006 Jan; 52(1):61-6. PubMed ID: 16368462
[TBL] [Abstract][Full Text] [Related]
14. Meningococcal disease in Arkansas.
J Ark Med Soc; 1997 Apr; 93(11):558-9. PubMed ID: 9114649
[No Abstract] [Full Text] [Related]
15. Changes in cancer incidence patterns among a northeastern American Indian population: 1955-1969 versus 1990-2004.
Mahoney MC; Va P; Stevens A; Kahn AR; Michalek AM
J Rural Health; 2009; 25(4):378-83. PubMed ID: 19780918
[TBL] [Abstract][Full Text] [Related]
16. Meningococcal disease in Ontario during the winter of 1988-1989.
Heimann GA; Mikel DE; Naus M; Goel V; Tischler M; Carlson JA; Schabas R; Pasut G; Borczyk A; Krishnan C
Can Dis Wkly Rep; 1989 Mar; 15(11):59-62. PubMed ID: 2713946
[No Abstract] [Full Text] [Related]
17. Update on meningococcal disease mortality in the United States since 2002.
Kim GY; Sorvillo F; Kuo T
Pediatr Infect Dis J; 2010 Jul; 29(7):681. PubMed ID: 20574406
[No Abstract] [Full Text] [Related]
18. The impact of childhood meningococcal serogroup C conjugate vaccine programs in Canada.
Bettinger JA; Scheifele DW; Le Saux N; Halperin SA; Vaudry W; Tsang R;
Pediatr Infect Dis J; 2009 Mar; 28(3):220-4. PubMed ID: 19209096
[TBL] [Abstract][Full Text] [Related]
19. Meningococcal infections in England and Wales: 1992.
Jones DM; Kaczmarski EB
Commun Dis Rep CDR Rev; 1993 Aug; 3(9):R129-31. PubMed ID: 7693173
[TBL] [Abstract][Full Text] [Related]
20. An update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS).
National Advisory Committee on Immunization (NACI)
Can Commun Dis Rep; 2009 Apr; 35(ACS-3):1-40. PubMed ID: 19400026
[No Abstract] [Full Text] [Related]
[Next] [New Search]
